Literature DB >> 27936891

Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?

Mirko Nitsche1,2, Werner Brannath3, Matthias Brückner3, Dirk Wagner1, Alexander Kaltenborn4,5, Nils Temme1, Robert M Hermann1,6.   

Abstract

OBJECTIVE: The objective of this retrospective planning study was to find a contouring definition for the rectum as an organ at risk (OAR) in curative three-dimensional external beam radiotherapy (EBRT) for prostate cancer (PCa) with a predictive correlation between the dose-volume histogram (DVH) and rectal toxicity.
METHODS: In a pre-study, the planning CT scans of 23 patients with PCa receiving definitive EBRT were analyzed. The rectum was contoured according to 13 different definitions, and the dose distribution was correlated with the respective rectal volumes by generating DVH curves. Three definitions were identified to represent the most distinct differences in the shapes of the DVH curves: one anatomical definition recommended by the Radiation Therapy Oncology Group (RTOG) and two functional definitions based on the target volume. In the main study, the correlation between different relative DVH parameters derived from these three contouring definitions and the occurrence of rectal toxicity during and after EBRT was studied in two consecutive collectives. The first cohort consisted of 97 patients receiving primary curative EBRT and the second cohort consisted of 66 patients treated for biochemical recurrence after prostatectomy. Rectal toxicity was investigated by clinical investigation and scored according to the Common Terminology Criteria for Adverse Events. Candidate parameters were the volume of the rectum, mean dose, maximal dose, volume receiving at least 60 Gy (V60), area under the DVH curve up to 25 Gy and area under the DVH curve up to 75 Gy in dependence of each chosen rectum definition. Multivariable logistic regression considered other clinical factors such as pelvine lymphatics vs local target volume, diabetes, prior rectal surgery, anticoagulation or haemorrhoids too.
RESULTS: In Cohort 1 (primary EBRT), the mean rectal volumes for definitions "RTOG", planning target volume "(PTV)-based" and "PTV-linked" were 100 cm3 [standard deviation (SD) 43 cm3], 60 cm3 (SD 26 cm3) and 74 cm3 (SD 31 cm3), respectively (p < 0.01; analysis of variance). The mean rectal doses according to these definitions were 35 Gy (SD 8 Gy), 48 Gy (SD 4 Gy) and 44 Gy (SD 5 Gy) (p < 0.01). In Cohort 2 (salvage EBRT), the mean rectal volumes were 114 cm3 (SD 47 cm3), 64 cm3 (SD 26 cm3) and 81 cm3 (SD 30 cm3) (p < 0.01) and the mean doses received by the rectum were 36 Gy (SD 8 Gy), 49 Gy (SD 5 Gy) and 44 Gy (SD 5 Gy) (p < 0.01). Acute or subacute rectal inflammation occurred in 69 (71.9%) patients in Cohort 1 and in 43 (70.5%) in Cohort 2. We did not find a correlation between all investigated DVH parameters and rectal toxicity, irrespective of the investigated definition. By adding additional variables in multivariate analysis, the predictive ability was substantially improved. Still, there was essentially no difference in the probability of predicting rectal inflammation occurrence between the tested contouring definitions.
CONCLUSION: The RTOG anatomy-based recommendations are questionable in comparison with functional definitions, as they result in higher variances in several relative DVH parameters. Moreover, the anatomy-based definition is no better and no worse in the predictive value concerning clinical end points. Advances in knowledge: Functional definitions for the rectum as OAR are easier to apply, faster to contour, have smaller variances and do not offer less information than the anatomy-based RTOG definition.

Entities:  

Mesh:

Year:  2016        PMID: 27936891      PMCID: PMC5685105          DOI: 10.1259/bjr.20160370

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  34 in total

1.  Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models.

Authors:  Matthias Söhn; Di Yan; Jian Liang; Elisa Meldolesi; Carlos Vargas; Markus Alber
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-01-26       Impact factor: 7.038

2.  Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer.

Authors:  Hans Paul van der Laan; Alphons van den Bergh; Cornelis Schilstra; Renske Vlasman; Harm Meertens; Johannes A Langendijk
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-10       Impact factor: 7.038

3.  Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.

Authors:  Susan L Tucker; Lei Dong; Rex Cheung; Jennifer Johnson; Radhe Mohan; Eugene H Huang; H Helen Liu; Howard D Thames; Deborah Kuban
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-12-01       Impact factor: 7.038

4.  Comparison of prostate cancer treatment in two institutions: a quality control study.

Authors:  C Rasch; P Remeijer; P C Koper; G J Meijer; J C Stroom; M van Herk; J V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-11-01       Impact factor: 7.038

5.  Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter study.

Authors:  Vittorio Vavassori; Claudio Fiorino; Tiziana Rancati; Alessandro Magli; Gianni Fellin; Michela Baccolini; Carla Bianchi; Emanuela Cagna; Flora A Mauro; Angelo F Monti; Fernando Munoz; Michele Stasi; Paola Franzone; Riccardo Valdagni
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-01-22       Impact factor: 7.038

6.  Low interrater reliability in grading of rectal bleeding using National Cancer Institute Common Toxicity Criteria and Radiation Therapy Oncology Group Toxicity scales: a survey of radiation oncologists.

Authors:  Minh-Phuong Huynh-Le; Zhe Zhang; Phuoc T Tran; Theodore L DeWeese; Daniel Y Song
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-10-13       Impact factor: 7.038

7.  Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer.

Authors:  Eugene H Huang; Alan Pollack; Larry Levy; George Starkschall; Lei Dong; Isaac Rosen; Deborah A Kuban
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-12-01       Impact factor: 7.038

8.  Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer.

Authors:  Claudio Fiorino; Giuseppe Sanguineti; Cesare Cozzarini; Gianni Fellin; Franca Foppiano; Loris Menegotti; Anna Piazzolla; Vittorio Vavassori; Riccardo Valdagni
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-11-15       Impact factor: 7.038

9.  Hazards of dose escalation in prostate cancer radiotherapy.

Authors:  Deborah Kuban; Alan Pollack; Eugene Huang; Larry Levy; Lei Dong; George Starkschall; Isaac Rosen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-12-01       Impact factor: 7.038

10.  Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).

Authors:  T Rancati; C Fiorino; G Gagliardi; G M Cattaneo; G Sanguineti; V Casanova Borca; C Cozzarini; G Fellin; F Foppiano; G Girelli; L Menegotti; A Piazzolla; V Vavassori; R Valdagni
Journal:  Radiother Oncol       Date:  2004-10       Impact factor: 6.280

View more
  1 in total

1.  Autosegmentation based on different-sized training datasets of consistently-curated volumes and impact on rectal contours in prostate cancer radiation therapy.

Authors:  Caroline Elisabeth Olsson; Rahul Suresh; Jarkko Niemelä; Saad Ullah Akram; Alexander Valdman
Journal:  Phys Imaging Radiat Oncol       Date:  2022-05-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.